Abstract:Objective:This study was to evaluate the efficacy of breast conserving operation plus radiotherapy in breast cancer (stage IIIa) and the independent prognosis factor. In addition,we investigate optimized radiation dose and fields. Methods:Cases were patients who received breast-conserving therapy (BCT,n=139) from 2001 to 2008 in our hospital. Control group were patients who received modified radical masectomy (MRM,n=88). In BCT group,tangential field irradiation was used with dose of 46-50 Gy. Tumor bed was irradiated additional 10 Gy with electron beams. Supraclavicular field irradiation was also used with dose of 50 Gy. Among the 88 cases treated with MRM,20 cases were treated with supraclavicular field irradiation plus internal mammary radiation,and 16 cases were treated with supraclavicular field irradiation plus chest wall. Beside the different doses and fields,the efficacy of radiotherapy for breast cancer (stage IIIa) was estimated. Results:There was no significance difference in survival rate of IIIa stage patients after rational chemotherapy or endocrine therapy between BCT group and MRM group(P0.05). The efficacy and side-effects were not significantly different between 46 Gy group and 50 Gy group either. moreover we found that internal mammary radiation could contribute to higher incidence rate of adverse effect of lung and heart(P0.05),but had no effect on survival rate(P0.05). Additionally,our analysis showed that irradiation dose,whether perform supraclavicular field irradiation or not,and silver clip had no effect on survival rate. Cox regression analysis showed that only axillary lymph node status was an independent prognosis factor(P0.01). Conclusions:Breast-conserving therapy should be the choice for the patients with breast cancer (stage IIIa) according to the indication. Internal mammary field and axillary field are not advocated in patients with breast cancer. The silver clips have no effect on survival rate of the patients with small breasts.

The Radiotherapy after the Conservative Surgery for Patients with Breast Cancer-Technology and Indication